ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 587,17
-0,60%
Dow Jones
40 211,72
0,53%
DAX
18 502,96
-0,52%
Brent Oil
83,68
-0,78%
Bitcoin
63 034,23
-2,80%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Portola Pharmaceuticals Inc (PTLA)

  7. Portola Pharmaceuticals Inc (PTLA) Actualités

PTLA

Portola Pharmaceuticals (PTLA)

Portola Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTLA
DateHeureSourceTitreSymboleSociété
15/11/201314h12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: -2-NASDAQ:PTLAPortola Pharmaceuticals Inc
15/11/201314h12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest SalesNASDAQ:PTLAPortola Pharmaceuticals Inc
15/11/201314h12Dow Jones NewsFidelity Management & Research Co. 3Q 13F: Largest PurchasesNASDAQ:PTLAPortola Pharmaceuticals Inc
11/11/201314h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Additional Positive Phase 2 Proof-of-Concept Data for Andexanet Alfa (PRT4445*)NASDAQ:PTLAPortola Pharmaceuticals Inc
06/11/201323h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTLAPortola Pharmaceuticals Inc
05/11/201322h00GlobeNewswire Inc.Portola Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
31/10/201313h00GlobeNewswire Inc.Portola Pharmaceuticals to Announce Third Quarter 2013 Financial Results and Host Conference Call on Tuesday, November 5, 201...NASDAQ:PTLAPortola Pharmaceuticals Inc
24/10/201322h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Enrollment Has Begun in Phase 1/2 Study of PRT2070, an Oral Dual Syk/JAK Inhibitor for Gene...NASDAQ:PTLAPortola Pharmaceuticals Inc
17/10/201322h41Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:PTLAPortola Pharmaceuticals Inc
17/10/201314h32GlobeNewswire Inc.Portola Announces Pricing of Public Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
17/10/201312h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTLAPortola Pharmaceuticals Inc
16/10/201323h26Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:PTLAPortola Pharmaceuticals Inc
16/10/201312h56GlobeNewswire Inc.Portola Pharmaceuticals Announces Proposed Offering of Common StockNASDAQ:PTLAPortola Pharmaceuticals Inc
15/10/201323h05GlobeNewswire Inc.Portola Pharmaceuticals Announces Release of Lock-up Restriction for Common Stock Held by a Director of the CompanyNASDAQ:PTLAPortola Pharmaceuticals Inc
14/10/201323h05GlobeNewswire Inc.Portola Pharmaceuticals Announces First Phase 2 Results Demonstrating Extended Duration Infusion With Andexanet Alfa (PRT4445...NASDAQ:PTLAPortola Pharmaceuticals Inc
09/10/201314h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Initiation of Phase 1/2 Clinical Study of PRT2070NASDAQ:PTLAPortola Pharmaceuticals Inc
07/10/201322h52Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:PTLAPortola Pharmaceuticals Inc
20/09/201312h00MarketwiredVital Therapies, Inc. Expands Board of DirectorsNASDAQ:PTLAPortola Pharmaceuticals Inc
05/09/201314h00GlobeNewswire Inc.Portola Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:PTLAPortola Pharmaceuticals Inc
29/08/201314h00Business WirePortola Pharmaceuticals Announces Presentation of Preclinical Data on Andexanet Alfa (PRT44545), Factor Xa Inhibitor Antidote...NASDAQ:PTLAPortola Pharmaceuticals Inc
15/08/201314h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTLAPortola Pharmaceuticals Inc
15/08/201313h55Business WirePortola Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:PTLAPortola Pharmaceuticals Inc
07/08/201322h30Business WirePortola Pharmaceuticals to Announce Second Quarter 2013 Financial Results and Host Conference Call on Thursday, August 15, 2013NASDAQ:PTLAPortola Pharmaceuticals Inc
26/07/201316h23Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PTLAPortola Pharmaceuticals Inc
08/07/201323h00ZacksBayer Announces Positive Phase I Data - Analyst BlogNASDAQ:PTLAPortola Pharmaceuticals Inc
02/07/201313h30MarketwiredPortola Announces Positive Phase 2 Study Results Showing Factor Xa Inhibitor Antidote PRT4445 Reverses Anticoagulant Activity...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/06/201322h00MarketwiredPortola to Initiate Phase 2 Study Evaluating the Safety and Effectiveness of Its Factor Xa Inhibitor Antidote PRT4445 in Reve...NASDAQ:PTLAPortola Pharmaceuticals Inc
26/06/201314h00MarketwiredPortola Announces Oral Presentation of Phase 2 Data on PRT4445, Factor Xa Inhibitor Antidote, at 2013 International Society o...NASDAQ:PTLAPortola Pharmaceuticals Inc
12/06/201322h00MarketwiredPortola Pharmaceuticals to Present at the Wells Fargo Securities Research and Economics 2013 Healthcare ConferenceNASDAQ:PTLAPortola Pharmaceuticals Inc
07/06/201323h01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTLAPortola Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTLA

Dernières Valeurs Consultées

LSE
CBUG
Ish Ust 3-7yr ?
NASDAQ
ALORW
ALSP Orchid Acquisition ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés